Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
Genetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signa...
Saved in:
Main Authors: | Jan Mersmann, Franziska Iskandar, Kathrina Latsch, Katharina Habeck, Vera Sprunck, René Zimmermann, Ralf R. Schumann, Kai Zacharowski, Alexander Koch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/174168 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toll-Like Receptors in Hepatic Ischemia/Reperfusion and Transplantation
by: John Evankovich, et al.
Published: (2010-01-01) -
Huang Qi Tong Bi Decoction Attenuates Myocardial Ischemia-Reperfusion Injury via HMGB1/TLR/NF-κB Pathway
by: Kun Liu, et al.
Published: (2019-01-01) -
Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy
by: Wenwen Wang, et al.
Published: (2019-01-01) -
IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway.
by: Ruisong Ma, et al.
Published: (2025-01-01) -
Role of cytokines in myocardial ischemia and reperfusion
by: H. S. Sharma, et al.
Published: (1997-01-01)